Arcadia Biosciences (NASDAQ:RKDA) Coverage Initiated at StockNews.com

Research analysts at StockNews.com initiated coverage on shares of Arcadia Biosciences (NASDAQ:RKDA) in a research report issued on Friday. The firm set a “sell” rating on the basic materials company’s stock.

Separately, HC Wainwright reissued a “buy” rating and issued a $6.00 price target on shares of Arcadia Biosciences in a research note on Wednesday, August 21st.

Arcadia Biosciences Price Performance

Shares of NASDAQ RKDA opened at $2.90 on Friday. The company has a 50 day simple moving average of $3.34 and a 200 day simple moving average of $3.02. The firm has a market cap of $3.94 million, a PE ratio of -0.68 and a beta of 1.27. Arcadia Biosciences has a 1 year low of $1.85 and a 1 year high of $5.34.

Arcadia Biosciences Company Profile

Arcadia Biosciences, Inc produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring.